• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Role of mitochondrial depolarization and disrupted mitochondrial homeostasis in non-alcoholic steatohepatitis and fibrosis in mice.线粒体去极化和线粒体稳态破坏在小鼠非酒精性脂肪性肝炎和肝纤维化中的作用。
Int J Physiol Pathophysiol Pharmacol. 2019 Oct 15;11(5):190-204. eCollection 2019.
2
Mitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced non-alcoholic steatohepatitis.线粒体基因多态性改变肝脏细胞能量代谢并加重饮食诱导的非酒精性脂肪性肝炎。
Mol Metab. 2016 Feb 2;5(4):283-295. doi: 10.1016/j.molmet.2016.01.010. eCollection 2016 Apr.
3
Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.在小鼠的高脂肪-高胆固醇-高糖饮食模型中,非酒精性脂肪变性进展为脂肪性肝炎和肝纤维化与促进炎症和肝肿瘤的危险信号的累积平行。
J Transl Med. 2015 Jun 16;13:193. doi: 10.1186/s12967-015-0552-7.
4
Roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with non-alcoholic steatohepatitis.Roux-en-y 胃旁路手术可减轻非酒精性脂肪性肝炎小鼠的肝线粒体功能障碍。
Gut. 2015 Apr;64(4):673-83. doi: 10.1136/gutjnl-2014-306748. Epub 2014 Jun 10.
5
Progression and Regression of Hepatic Lesions in a Mouse Model of NASH Induced by Dietary Intervention and Its Implications in Pharmacotherapy.饮食干预诱导的非酒精性脂肪性肝炎小鼠模型中肝脏病变的进展与消退及其在药物治疗中的意义
Front Pharmacol. 2018 May 1;9:410. doi: 10.3389/fphar.2018.00410. eCollection 2018.
6
Deletion of Thioredoxin-interacting protein ameliorates high fat diet-induced non-alcoholic steatohepatitis through modulation of Toll-like receptor 2-NLRP3-inflammasome axis: Histological and immunohistochemical study.硫氧还蛋白相互作用蛋白的缺失通过调节Toll样受体2-NLRP3炎性小体轴改善高脂饮食诱导的非酒精性脂肪性肝炎:组织学和免疫组化研究
Acta Histochem. 2018 Apr;120(3):242-254. doi: 10.1016/j.acthis.2018.02.006. Epub 2018 Feb 23.
7
[Establishment of a complex alcoholic liver fibrosis mouse model and investigation of OPN and TGF-beta1 hepatic expression].[复合性酒精性肝纤维化小鼠模型的建立及骨桥蛋白和转化生长因子-β1肝脏表达的研究]
Zhonghua Gan Zang Bing Za Zhi. 2013 Mar;21(3):207-12.
8
The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose.FATZO小鼠是2型糖尿病的下一代模型,在喂食添加了果糖的西式饮食时会发展为非酒精性脂肪性肝病(NAFLD)和非酒精性脂肪性肝炎(NASH)。
BMC Gastroenterol. 2019 Mar 18;19(1):41. doi: 10.1186/s12876-019-0958-4.
9
Imaging Fibrogenesis in a Diet-Induced Model of Nonalcoholic Steatohepatitis (NASH).成像肝纤维化在饮食诱导的非酒精性脂肪性肝炎(NASH)模型中。
Contrast Media Mol Imaging. 2019 Dec 1;2019:6298128. doi: 10.1155/2019/6298128. eCollection 2019.
10
Experimental non-alcoholic steatohepatitis in Göttingen Minipigs: consequences of high fat-fructose-cholesterol diet and diabetes.实验性非酒精性脂肪性肝炎在哥廷根小型猪中的表现:高脂肪-果糖-胆固醇饮食和糖尿病的影响。
J Transl Med. 2019 Apr 3;17(1):110. doi: 10.1186/s12967-019-1854-y.

引用本文的文献

1
Immune Microenvironment on the Molecular Mechanisms and Therapeutic Targets of MAFLD.免疫微环境对MAFLD分子机制及治疗靶点的影响
Immunotargets Ther. 2025 Jul 11;14:719-733. doi: 10.2147/ITT.S530451. eCollection 2025.
2
Mitochondria at the Crossroads: Linking the Mediterranean Diet to Metabolic Health and Non-Pharmacological Approaches to NAFLD.线粒体处于十字路口:将地中海饮食与代谢健康及非酒精性脂肪性肝病的非药物治疗方法联系起来。
Nutrients. 2025 Mar 30;17(7):1214. doi: 10.3390/nu17071214.
3
The Role of Mitochondrial Quality Control in Liver Diseases: Dawn of a Therapeutic Era.线粒体质量控制在肝脏疾病中的作用:治疗时代的曙光
Int J Biol Sci. 2025 Feb 10;21(4):1767-1783. doi: 10.7150/ijbs.107777. eCollection 2025.
4
Crosstalk between Epigenetics and Metabolic Reprogramming in Metabolic Dysfunction-Associated Steatotic Liver Disease-Induced Hepatocellular Carcinoma: A New Sight.代谢功能障碍相关脂肪性肝病诱导的肝细胞癌中表观遗传学与代谢重编程之间的串扰:新视角
Metabolites. 2024 Jun 8;14(6):325. doi: 10.3390/metabo14060325.
5
MASH as an emerging cause of hepatocellular carcinoma: current knowledge and future perspectives.MASH作为肝细胞癌的一种新兴病因:当前认知与未来展望。
Mol Oncol. 2025 Feb;19(2):275-294. doi: 10.1002/1878-0261.13685. Epub 2024 Jun 14.
6
Mitochondrial quality control in human health and disease.线粒体质量控制在人类健康与疾病中的作用。
Mil Med Res. 2024 May 29;11(1):32. doi: 10.1186/s40779-024-00536-5.
7
Thyroid Hormone and Mitochondrial Dysfunction: Therapeutic Implications for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).甲状腺激素与线粒体功能障碍:代谢功能障碍相关脂肪性肝病(MASLD)的治疗意义。
Cells. 2023 Dec 9;12(24):2806. doi: 10.3390/cells12242806.
8
Mitochondrial Quality Control: Its Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).线粒体质量控制:其在代谢功能障碍相关脂肪性肝病(MASLD)中的作用
J Obes Metab Syndr. 2023 Dec 30;32(4):289-302. doi: 10.7570/jomes23054. Epub 2023 Dec 5.
9
Copine7 deficiency leads to hepatic fat accumulation via mitochondrial dysfunction.Copine7缺乏通过线粒体功能障碍导致肝脏脂肪堆积。
Heliyon. 2023 Oct 28;9(11):e21676. doi: 10.1016/j.heliyon.2023.e21676. eCollection 2023 Nov.
10
Evaluation of the efficacy of mitochondrial fission inhibitor (Mdivi-1) using non-alcoholic steatohepatitis (NASH) liver organoids.使用非酒精性脂肪性肝炎(NASH)肝脏类器官评估线粒体分裂抑制剂(Mdivi-1)的疗效。
Front Pharmacol. 2023 Oct 12;14:1243258. doi: 10.3389/fphar.2023.1243258. eCollection 2023.

本文引用的文献

1
Mitochondria-Mediated Pathogenesis and Therapeutics for Non-Alcoholic Fatty Liver Disease.线粒体介导的非酒精性脂肪肝病发病机制与治疗学
Mol Nutr Food Res. 2019 Aug;63(16):e1900043. doi: 10.1002/mnfr.201900043. Epub 2019 Jun 19.
2
A Unifying Hypothesis Linking Hepatic Adaptations for Ethanol Metabolism to the Proinflammatory and Profibrotic Events of Alcoholic Liver Disease.将乙醇代谢的肝脏适应性与酒精性肝病的炎症和纤维化事件联系起来的统一假说。
Alcohol Clin Exp Res. 2018 Nov;42(11):2072-2089. doi: 10.1111/acer.13877. Epub 2018 Sep 17.
3
Mitochondrial Dysfunction and Signaling in Chronic Liver Diseases.慢性肝脏疾病中的线粒体功能障碍与信号转导
Gastroenterology. 2018 Sep;155(3):629-647. doi: 10.1053/j.gastro.2018.06.083. Epub 2018 Aug 2.
4
Impaired TFEB-Mediated Lysosome Biogenesis and Autophagy Promote Chronic Ethanol-Induced Liver Injury and Steatosis in Mice.TFEB 介导线粒体生物发生和自噬受损促进慢性乙醇诱导的小鼠肝损伤和脂肪变性。
Gastroenterology. 2018 Sep;155(3):865-879.e12. doi: 10.1053/j.gastro.2018.05.027. Epub 2018 May 18.
5
Mesalazine, an osteopontin inhibitor: The potential prophylactic and remedial roles in induced liver fibrosis in rats.美沙拉嗪,骨桥蛋白抑制剂:在诱导大鼠肝纤维化中的潜在预防和治疗作用。
Chem Biol Interact. 2018 Jun 1;289:109-118. doi: 10.1016/j.cbi.2018.05.002. Epub 2018 May 5.
6
Formation of p62-positive inclusion body is associated with macrophage polarization in non-alcoholic fatty liver disease.p62阳性包涵体的形成与非酒精性脂肪性肝病中的巨噬细胞极化有关。
Hepatol Res. 2018 Aug;48(9):757-767. doi: 10.1111/hepr.13071. Epub 2018 Apr 10.
7
Cyclophilin D deficiency attenuates mitochondrial perturbation and ameliorates hepatic steatosis.环孢素 D 缺乏可减轻线粒体扰动并改善肝脂肪变性。
Hepatology. 2018 Jul;68(1):62-77. doi: 10.1002/hep.29788. Epub 2018 May 9.
8
Mitochondria in non-alcoholic fatty liver disease.非酒精性脂肪性肝病中的线粒体。
Int J Biochem Cell Biol. 2018 Feb;95:93-99. doi: 10.1016/j.biocel.2017.12.019. Epub 2017 Dec 26.
9
Mitochondrial adaptation in steatotic mice.肝脂肪变性小鼠的线粒体适应。
Mitochondrion. 2018 May;40:1-12. doi: 10.1016/j.mito.2017.08.015. Epub 2017 Sep 19.
10
Mouse models of nonalcoholic steatohepatitis in preclinical drug development.非酒精性脂肪性肝炎的小鼠模型在临床前药物研发中的应用。
Drug Discov Today. 2017 Nov;22(11):1707-1718. doi: 10.1016/j.drudis.2017.06.007. Epub 2017 Jul 4.

线粒体去极化和线粒体稳态破坏在小鼠非酒精性脂肪性肝炎和肝纤维化中的作用。

Role of mitochondrial depolarization and disrupted mitochondrial homeostasis in non-alcoholic steatohepatitis and fibrosis in mice.

作者信息

Krishnasamy Yasodha, Gooz Monika, Li Li, Lemasters John J, Zhong Zhi

机构信息

Department of Drug Discovery and Biomedical Sciences, Medical University of South Carolina Charleston, SC 29425, USA.

Department of Biochemistry and Molecular Biology, Medical University of South Carolina Charleston, SC 29425, USA.

出版信息

Int J Physiol Pathophysiol Pharmacol. 2019 Oct 15;11(5):190-204. eCollection 2019.

PMID:31777643
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6872485/
Abstract

The pathogenesis of non-alcoholic steatohepatitis (NASH) is poorly understood. Here, relationships between mitochondrial depolarization (mtDepo) and mitochondrial homeostasis were studied in a mouse model of NASH. C57BL/6 mice were fed a Western diet (high fat, fructose and cholesterol) for 2 weeks, 2 months and 6 months, and livers were harvested for histology and biochemical analysis. Hepatic mtDepo was evaluated by intravital multiphoton microscopy. After Western diet feeding, mixed hepatic micro- and macrovesicular steatosis and leukocyte infiltration occurred at 2 weeks and continued to increase afterwards. ALT release, mild necrosis, apoptosis, and ballooning degeneration were present at 2 and 6 months. Smooth muscle α-actin expression increased at 2 weeks and longer, and increased collagen-I expression and mild fibrosis occurred at 6 months. After feeding Western diet for 2 weeks and longer, mtDepo appeared in 50-70% hepatocytes, indicating mitochondrial dysfunction at an early stage of NASH. mtDepo can initiate mitophagy, and mitophagic markers increased at 2 and 6 months. Concurrently autophagic processing became impaired. Oxidative phosphorylation proteins, mitochondrial biogenesis signals, and proteins associated with mitochondrial fission and fusion decreased after 2 months and longer of Western diet. Proinflammatory and profibrotic signaling (NLRP3 inflammasome activation, expression of IL-1, osteopontin and TGF-β1) also increased in association with mitochondrial stress/dysfunction after Western diet feeding. Taken together, we show that hepatic mtDepo occurs early in mice fed a Western diet, followed by increased mitophagic burden, suppressed mitochondrial biogenesis and dynamics, and mitochondrial depletion. These novel mitochondrial alterations in NASH most likely play an important role in promoting steatosis, inflammation, and progression to fibrosis.

摘要

非酒精性脂肪性肝炎(NASH)的发病机制尚不清楚。在此,我们在NASH小鼠模型中研究了线粒体去极化(mtDepo)与线粒体稳态之间的关系。将C57BL/6小鼠喂食西方饮食(高脂肪、果糖和胆固醇)2周、2个月和6个月,然后采集肝脏进行组织学和生化分析。通过活体多光子显微镜评估肝脏mtDepo。喂食西方饮食后,在2周时出现混合性肝微泡和大泡性脂肪变性以及白细胞浸润,之后持续增加。在2个月和6个月时出现谷丙转氨酶(ALT)释放、轻度坏死、凋亡和气球样变性。平滑肌α-肌动蛋白表达在2周及更长时间增加,6个月时胶原蛋白-I表达增加且出现轻度纤维化。喂食西方饮食2周及更长时间后,50 - 70%的肝细胞出现mtDepo,表明NASH早期存在线粒体功能障碍。mtDepo可启动线粒体自噬,线粒体自噬标志物在2个月和6个月时增加。同时自噬过程受损。西方饮食2个月及更长时间后,氧化磷酸化蛋白、线粒体生物发生信号以及与线粒体分裂和融合相关的蛋白减少。西方饮食喂养后,促炎和促纤维化信号(NLRP3炎性小体激活、白细胞介素-1、骨桥蛋白和转化生长因子-β1的表达)也与线粒体应激/功能障碍相关增加。综上所述,我们表明在喂食西方饮食的小鼠中,肝脏mtDepo在早期出现,随后线粒体自噬负担增加、线粒体生物发生和动力学受到抑制以及线粒体耗竭。NASH中这些新的线粒体改变很可能在促进脂肪变性、炎症和纤维化进展中起重要作用。